Skip to main content

Solutions

Disruptive solutions
for different sectors and use cases.

Discover more

Hyris System™

The first multi-market platform able to deliver real value for the final customer, in a marketplace approach.

Discover more

Partners

Hyris System™ allows a wide range of operators and researchers to develop their own assays and kits.

Discover more

About Us

Hyris is a tech-bio company committed to democratise genetics and health insights.

Discover more

Latest

Read more
12 March 2025

Hyris expands testing rapid technology aimed at supporting the fight against malaria

15 May 2024

Hyris signs a distribution agreement with GrowBIGogh

20 February 2024

Hyris technology supports the fight against one of the world’s deadliest diseases, malaria.

15 January 2024

Hyris fulfils its integration into Ulisse Biomed to give birth to a new international group ready to make its mark in the global biotech market.

    Contact Us
    18 November, 2022
    Products & Partnerships

    Hyris and Singlabs signed a distributorship agreement for Singapore

    Hyris and Signlabs will partner together to commercialize Hyris signature technology, Hyris System™, and Hyris testing solutions in Singapore.

    Related links:

    Singlabs

    Back to Latest frontpage
    Back to Latest frontpage

    Hyris expands testing rapid technology aimed at supporting the fight against malaria

    CONTINUE TO READING

    Hyris signs a distribution agreement with GrowBIGogh

    CONTINUE TO READING

    Hyris technology supports the fight against one of the world’s deadliest diseases, malaria.

    CONTINUE TO READING

    Hyris fulfils its integration into Ulisse Biomed to give birth to a new international group ready to make its mark in the global biotech market.

    CONTINUE TO READING

    Distribution agreement renewal with Biomol Laboratories, fostering the partnership in the field of personalised medicine

    CONTINUE TO READING

    Hyris' signed a binding agreement for a reverse take-over, leading to a new integrated entity with Ulisse Biomed

    CONTINUE TO READING

    Hyris' new onboarding programs support researchers and developers to launch testing kits.

    CONTINUE TO READING

    Hyris Founder&CEO Stefano Lo Priore interviewed by Carter&Benson

    CONTINUE TO READING

    Hyris and Singlabs signed a distributorship agreement for Singapore

    CONTINUE TO READING

    Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.

    CONTINUE TO READING
      12 March 2025

      Hyris expands testing rapid technology aimed at supporting the fight against malaria

      CONTINUE TO READING
      15 May 2024

      Hyris signs a distribution agreement with GrowBIGogh

      CONTINUE TO READING
      20 February 2024

      Hyris technology supports the fight against one of the world’s deadliest diseases, malaria.

      CONTINUE TO READING
      15 January 2024

      Hyris fulfils its integration into Ulisse Biomed to give birth to a new international group ready to make its mark in the global biotech market.

      CONTINUE TO READING
      10 January 2024

      Distribution agreement renewal with Biomol Laboratories, fostering the partnership in the field of personalised medicine

      CONTINUE TO READING
      04 December 2023

      Hyris' signed a binding agreement for a reverse take-over, leading to a new integrated entity with Ulisse Biomed

      CONTINUE TO READING
      29 September 2023

      Hyris' new onboarding programs support researchers and developers to launch testing kits.

      CONTINUE TO READING
      29 June 2023

      Hyris Founder&CEO Stefano Lo Priore interviewed by Carter&Benson

      CONTINUE TO READING
      18 November 2022

      Hyris and Singlabs signed a distributorship agreement for Singapore

      CONTINUE TO READING
      02 November 2022

      Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.

      CONTINUE TO READING